Company Profile
Updated: 14-DEC-09CRADA International Inc.
Private Company, Headquarters Location
261 Chastain Manor Dr., Norcross, GA 30071, United States
(770)447-1812, (770)447-1812 fax,
Primary SIC: Business Consulting Services, Not Elsewhere Classified, Primary NAICS: Other Management Consulting Services
Description: Services: A research development company. Focuses on the active implementation and development of grants and contracts program. Emphasizes strategic planning methodology, the establishment of cooperative research and development alliances for its institutional associates. Strategic areas: counter terrorism (chem/bio/nuclear); information security (counter-cyber terrorism); space science: systems engineering.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/3/2009; 1755 words; ...published in the International Journal of Oncology...mesothelioma. o Biogen Idec Inc., of Cambridge...Cell Therapeutics Inc., of Seattle...Development Agreement (CRADA) with the National...The five-year CRADA will focus on human...Ceragenix Pharmaceuticals Inc., of Denver, said...
Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo's Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis.(Clinical report)
Biotech Week; 10/7/2009; 1595 words; Enzo Biochem, Inc. (NYSE: ENZ), announced...Development Agreement (CRADA) with the National...also Enzo Biochem, Inc.). Under the terms of the CRADA, Enzo will supply its...rights to both US and international patents claiming the...
NIH and Enzo Biochem to Conduct Clinical Trial with Optiquel.(Clinical report)
Health & Beauty Close-Up; 9/24/2009; 1149 words; Enzo Biochem, Inc. has announced that it...Development Agreement (CRADA) with the National Eye...Under the terms of the CRADA, Enzo will supply its proprietary...exclusive rights to both US and international patents claiming the use...
NIH and Enzo Biochem Partner to Conduct Clinical Trial with Optiquel
Wireless News; 9/24/2009; 746 words; ...News Enzo Biochem, Inc. has announced that...Development Agreement (CRADA) with the National Eye...Under the terms of the CRADA, Enzo will supply its...rights to both US and international patents claiming the...2009 Close-Up Media, Inc. All Rights Reserved...
Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo's Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis.
Business Wire; 9/21/2009; 1887 words; ...NEW YORK -- Enzo Biochem, Inc. (NYSE: ENZ), announced...and Development Agreement (CRADA) with the National Eye Institute...uveitis. Under the terms of the CRADA, Enzo will supply its proprietary...exclusive rights to both US and international patents claiming the use of...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning